文献类型：期刊文献

中文题名：中药解热作用研究进展

英文题名：Research progress on antipyretic effect of Chinese medicine

作者：陈升富[1,2,3];李晓琳[2,3];王维刚[1,2,3];杜玮泽[1,2,3];李茂星[1,2,3,4]

第一作者：陈升富

机构：[1]甘肃中医药大学药学院,兰州730000,甘肃;[2]联勤保障部队第九四〇医院临床药学科,甘肃兰州730050;[3]甘肃省高原药学行业技术中心,甘肃兰州730050;[4]兰州大学药学院,甘肃兰州730000

第一机构：甘肃中医药大学药学院（西北中藏药协同创新中心办公室）

年份：2022

卷号：27

期号：3

起止页码：334

中文期刊名：中国临床药理学与治疗学

外文期刊名：Chinese Journal of Clinical Pharmacology and Therapeutics

收录：CSTPCD;;CSCD:【CSCD_E2021_2022】；

基金：藏药现代化研究与开发创新团队(31920200010)。

语种：中文

中文关键词：发热;核转录因子κB信号通路;中药活性成分;解热

外文关键词：fever;nuclear transcription factorκB signaling pathway;active ingredients of traditional Chinese medicine;antipyretic

摘要：发热是机体受到感染和炎性疾病的标志,持续高热会导致细胞变性,引发多器官功能损伤,严重时会影响大脑神经及组织功能。虽然发热过程常见而又普通,但其病理机制涉及多个信号通路,如核转录因子κB信号通路、Toll样受体4信号通路等。大量研究表明,传统中药复方及其活性组分可以降低血清中炎性因子(TNF-α、IL-1β及IL-6)及下丘脑体温调节介质(PGE_(2)、cAMP),抑制NF-κB信号通路,有效抑制体温病理性升高。本文总结PubMed与中国知网数据库中相关文献,就中药活性成分及复方解热作用进行系统阐述,以期为利用传统中药治疗发热,挖掘新型退烧药物提供理论依据及研究思路。
Fever is a sign of infection and inflammatory diseases in the body.Persistent high fever will lead to cell degeneration,causing multiple organ dysfunction,and seriously affecting brain nerve and tissue function.Although the fever process is common and ordinary,its pathological mechanism involves multiple signaling pathways,such as nuclear transcription factorκB signaling pathway,Toll-like receptor 4 signaling pathway.A large number of studies have shown that traditional Chinese medicine compound and its active components can reduce serum inflammatory factors(TNF-α,IL-1βand IL-6)and hypothalamic thermoregulatory mediators(PGE_(2),cAMP),inhibit NF-κB signaling pathway,and effectively inhibit the pathological increase of body temperature.This paper summarizes the relevant literature in PubMed and CNKI database,and systematically expounds the active components of traditional Chinese medicine and the antipyretic effect of compound prescription,in order to provide theoretical basis and research ideas for the use of traditional Chinese medicine in the treatment of fever and the excavation of new anti-fever drugs.